Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
Status:
Terminated
Trial end date:
2021-04-15
Target enrollment:
Participant gender:
Summary
The aim of this trial is to assess if patients treated with the combination of ribociclib and
endocrine therapy respond to treatment as fast as patients treated with chemotherapy only,
without decreasing their quality of life (QoL).